-olol
A beta blocker: blocks adrenaline's beta receptors, slowing the heart and lowering blood pressure.
- Drugs ending in -olol: 37
- Approved somewhere: 22
- With a US drug page: 19
- Stem
- -olol
- Class
- Beta blockers
- Sub-stems
- -alol
- Most common targets
- ADRB1 (22), ADRB2 (15), Adrenergic receptor beta (2), AR (1), Adrenergic receptor alpha-2 (1), Adrenergic receptor alpha-1 (1), Adrenergic receptor (1), KCNH2 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -olol or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Acebutolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Atenolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Betaxolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Bisoprolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Carteolol | Approved | Adrenergic receptor beta | Adrenergic receptor beta antagonist |
| Esmolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Landiolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Levobunolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Metipranolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Nadolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Nebivolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Oxprenolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Penbutolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Pindolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor partial agonist |
| Propranolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Levobetaxolol | Phase 3 | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Stanozolol | Phase 2 | AR | Androgen Receptor agonist |
| Celiprolol | Approved | ADRB2, Adrenergic receptor alpha-2, ADRB1 | Beta-2 adrenergic receptor partial agonist |
| Metoprolol | Approved | ADRB1 | Beta-1 adrenergic receptor antagonist |
| Practolol | Approved | ADRB1 | Beta-1 adrenergic receptor inhibitor |
| Tertatolol | Approved | — | — |
| Timolol | Approved | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Alprenolol | Phase 2 | — | — |
| Befunolol | Phase 2 | — | — |
| Bevantolol | Phase 2 | — | — |
| Bopindolol | Phase 2 | — | — |
| Bucindolol | Phase 2 | ADRB1, ADRB2, Adrenergic receptor alpha-1 | Beta-1 adrenergic receptor antagonist |
| Bupranolol | Phase 2 | — | — |
| Cloranolol | Phase 2 | — | — |
| Epanolol | Phase 2 | — | — |
| Esatenolol | Phase 2 | — | — |
| Mepindolol | Phase 2 | — | — |
| Talinolol | Phase 2 | — | — |
| Labetalol | Approved | Adrenergic receptor | Adrenergic receptor antagonist |
| Sotalol | Approved | ADRB1, KCNH2, ADRB2 | Beta-1 adrenergic receptor antagonist |
| Dilevalol | — | Adrenergic receptor beta, ADRB2 | Adrenergic receptor beta antagonist |
| Pronetalol | — | ADRB1, ADRB2 | Beta-1 adrenergic receptor antagonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO